These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 16373709)

  • 21. Epidermal growth factor receptor-related protein inhibits cell growth and invasion in pancreatic cancer.
    Wang Z; Sengupta R; Banerjee S; Li Y; Zhang Y; Rahman KM; Aboukameel A; Mohammad R; Majumdar AP; Abbruzzese JL; Sarkar FH
    Cancer Res; 2006 Aug; 66(15):7653-60. PubMed ID: 16885366
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A novel copper complex of 3-benzoyl-alpha methyl benzene acetic acid with antitumor activity mediated via cyclooxygenase pathway.
    Ahmed F; Adsule S; Ali AS; Banerjee S; Ali S; Kulkarni S; Padhye S; Sarkar FH
    Int J Cancer; 2007 Feb; 120(4):734-42. PubMed ID: 17131340
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Genistein enhances the effect of epidermal growth factor receptor tyrosine kinase inhibitors and inhibits nuclear factor kappa B in nonsmall cell lung cancer cell lines.
    Gadgeel SM; Ali S; Philip PA; Wozniak A; Sarkar FH
    Cancer; 2009 May; 115(10):2165-76. PubMed ID: 19288574
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Antitumor activity of epidermal growth factor receptor-related protein is mediated by inactivation of ErbB receptors and nuclear factor-kappaB in pancreatic cancer.
    Zhang Y; Banerjee S; Wang Z; Xu H; Zhang L; Mohammad R; Aboukameel A; Adsay NV; Che M; Abbruzzese JL; Majumdar AP; Sarkar FH
    Cancer Res; 2006 Jan; 66(2):1025-32. PubMed ID: 16424038
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting endoplasmic reticulum stress and Akt with OSU-03012 and gefitinib or erlotinib to overcome resistance to epidermal growth factor receptor inhibitors.
    Wang YC; Kulp SK; Wang D; Yang CC; Sargeant AM; Hung JH; Kashida Y; Yamaguchi M; Chang GD; Chen CS
    Cancer Res; 2008 Apr; 68(8):2820-30. PubMed ID: 18413750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ErbB3 expression and dimerization with EGFR influence pancreatic cancer cell sensitivity to erlotinib.
    Frolov A; Schuller K; Tzeng CW; Cannon EE; Ku BC; Howard JH; Vickers SM; Heslin MJ; Buchsbaum DJ; Arnoletti JP
    Cancer Biol Ther; 2007 Apr; 6(4):548-54. PubMed ID: 17457047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Amiloride sensitizes human pancreatic cancer cells to erlotinib in vitro through inhibition of the PI3K/AKT signaling pathway.
    Zheng YT; Yang HY; Li T; Zhao B; Shao TF; Xiang XQ; Cai WM
    Acta Pharmacol Sin; 2015 May; 36(5):614-26. PubMed ID: 25864651
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Insulin-like growth factor-I antagonizes the antiproliferative effects of cyclooxygenase-2 inhibitors on BxPC-3 pancreatic cancer cells.
    Levitt RJ; Pollak M
    Cancer Res; 2002 Dec; 62(24):7372-6. PubMed ID: 12499282
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Simultaneously targeting epidermal growth factor receptor tyrosine kinase and cyclooxygenase-2, an efficient approach to inhibition of squamous cell carcinoma of the head and neck.
    Chen Z; Zhang X; Li M; Wang Z; Wieand HS; Grandis JR; Shin DM
    Clin Cancer Res; 2004 Sep; 10(17):5930-9. PubMed ID: 15355926
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Notch-1 down-regulation by curcumin is associated with the inhibition of cell growth and the induction of apoptosis in pancreatic cancer cells.
    Wang Z; Zhang Y; Banerjee S; Li Y; Sarkar FH
    Cancer; 2006 Jun; 106(11):2503-13. PubMed ID: 16628653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between epidermal growth factor receptor (EGFR) mutation and serum cyclooxygenase-2 Level, and the synergistic effect of celecoxib and gefitinib on EGFR expression in non-small cell lung cancer cells.
    Li N; Li H; Su F; Li J; Ma X; Gong P
    Int J Clin Exp Pathol; 2015; 8(8):9010-20. PubMed ID: 26464643
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.
    Kirane A; Toombs JE; Ostapoff K; Carbon JG; Zaknoen S; Braunfeld J; Schwarz RE; Burrows FJ; Brekken RA
    Clin Cancer Res; 2012 Sep; 18(18):5031-42. PubMed ID: 22829202
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Celecoxib induces apoptosis in cervical cancer cells independent of cyclooxygenase using NF-kappaB as a possible target.
    Kim SH; Song SH; Kim SG; Chun KS; Lim SY; Na HK; Kim JW; Surh YJ; Bang YJ; Song YS
    J Cancer Res Clin Oncol; 2004 Sep; 130(9):551-60. PubMed ID: 15197583
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Selective cyclooxygenase-2 inhibitors inhibit growth and induce apoptosis of bladder cancer.
    Gee J; Lee IL; Jendiroba D; Fischer SM; Grossman HB; Sabichi AL
    Oncol Rep; 2006 Feb; 15(2):471-7. PubMed ID: 16391871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Potent cell growth inhibitory effects in hepatitis B virus X protein positive hepatocellular carcinoma cells by the selective cyclooxygenase-2 inhibitor celecoxib.
    Xie H; Gao L; Chai N; Song J; Wang J; Song Z; Chen C; Pan Y; Zhao L; Sun S; Wu K; Feitelson MA; Liu J; Fan D
    Mol Carcinog; 2009 Jan; 48(1):56-65. PubMed ID: 18506760
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Preventing chemoresistance of human breast cancer cell line, MCF-7 with celecoxib.
    Chen C; Shen HL; Yang J; Chen QY; Xu WL
    J Cancer Res Clin Oncol; 2011 Jan; 137(1):9-17. PubMed ID: 20229271
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The selective cyclooxygenase-2 inhibitor nimesulide induces apoptosis in pancreatic cancer cells independent of COX-2.
    Eibl G; Reber HA; Wente MN; Hines OJ
    Pancreas; 2003 Jan; 26(1):33-41. PubMed ID: 12499915
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The nonsteroidal anti-inflammatory drug celecoxib suppresses the growth and induces apoptosis of human glioblastoma cells via the NF-κB pathway.
    Sareddy GR; Geeviman K; Ramulu C; Babu PP
    J Neurooncol; 2012 Jan; 106(1):99-109. PubMed ID: 21847707
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Down-regulation of Notch-1 contributes to cell growth inhibition and apoptosis in pancreatic cancer cells.
    Wang Z; Zhang Y; Li Y; Banerjee S; Liao J; Sarkar FH
    Mol Cancer Ther; 2006 Mar; 5(3):483-93. PubMed ID: 16546962
    [TBL] [Abstract][Full Text] [Related]  

  • 40. β2-adrenergic antagonists suppress pancreatic cancer cell invasion by inhibiting CREB, NFκB and AP-1.
    Zhang D; Ma QY; Hu HT; Zhang M
    Cancer Biol Ther; 2010 Jul; 10(1):19-29. PubMed ID: 20424515
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.